Dr. Stefani Reiko Takahashi, MD

Dr. Takahashi practices at USC Care Medical Group, Inc in La Canada Flintridge, California.

Dr. Takahashi's NPI, 1215961735, was assigned on July 10, 2006. Dr. Takahashi graduated from Keck School of Medicine of USC in 1994. Dr. Takahashi holds California license A55242.

Dr. Takahashi's primary practice is USC Care Medical Group, Inc, at 1751 Foothill Blvd, La Canada Flintridge, CA 91011 in Los Angeles County. The practice phone is (323) 442-5955.

Dr. Takahashi's primary practice is USC Care Medical Group, Inc in La Canada Flintridge, California. Dr. Takahashi is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Takahashi to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Takahashi practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Takahashi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Takahashi is board certified in dermatology by the American Board of Dermatology. Dr. Takahashi is licensed in California.

Dmand AI lists acne, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, itchy rashes, joint cyst and psoriasis among the conditions Dr. Takahashi treats.

CMS data shows 894 Medicare services from Dr. Takahashi across 9 procedure codes in 2024, for 228 Medicare patients. Medicare paid $46,955 for them. Every service was in an office.

CMS counts 228 Medicare patients who saw Dr. Takahashi in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Takahashi's median patient age at 57, with 61% women.

In 2024, Dr. Takahashi wrote 207 Medicare Part D claims for 92 patients. 93% of them were for generic drugs. CMS names the drug for 126 of them, across 7 drugs with 11 or more claims each, at $51,018 in total drug cost. In 2023, CMS named 72 claims across 3 drugs.

Dr. Takahashi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 327 procedures of removal of skin lesions by Dr. Takahashi, more than 83% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Takahashi in 2012.

Dmand AI links Dr. Takahashi to 4 clinical trials. Conditions studied include Eczema, Psoriasis and Dermatitis, Atopic. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Takahashi that name 2 trials.

CMS Open Payments shows 3 general payments to Dr. Takahashi from 3 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $19. It also lists 3 research payments totaling $4,539 from 2019 to 2022, naming 2 clinical trials.

Dmand AI lists 2 awards for Dr. Takahashi.

Dr. Takahashi graduated from Keck School of Medicine of USC in 1994. Dr. Takahashi is a member of AAD.

Dr. Takahashi is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.